Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation (NYSE: DDD) generates a steady flow of news across healthcare, aerospace and defense, industrial manufacturing, software and capital markets. As a pioneer in additive manufacturing, the company regularly issues updates on new 3D printers, materials, software platforms and application-specific solutions, as well as regulatory milestones and strategic partnerships.
Recent announcements highlight growth initiatives in aerospace and defense, where 3D Systems reports strong momentum in production printing systems and custom metal parts, expansion of its Littleton, Colorado A&D Application Center of Excellence, and participation in U.S. Air Force–sponsored programs for next-generation metal printing technologies. The company also shares developments from its NAMI joint venture in Saudi Arabia, including agreements in energy, infrastructure inspection and collaborations with major defense contractors.
In healthcare, news items include FDA 510(k) clearance expanding indications for the VSP Orthopedics virtual surgical planning platform to skeletally mature adolescents, along with commentary on the role of personalized healthcare and patient-specific devices in the company’s Med Tech business. Product-focused releases cover new stereolithography solutions such as the SLA 825 Dual, investment casting tools like ArrayCast and Accura SbF, and jewelry-focused systems such as the MJP 300W Plus wax printer.
Investors will also find financial and corporate updates, including quarterly earnings releases, software strategy announcements involving 3D Sprint, Oqton MOS and 3DXpert, and transactions related to convertible notes and capital structure. This news page brings together these diverse updates so readers can follow how 3D Systems’ technologies, partnerships and financial decisions shape its role in additive manufacturing.
3D Systems and Saremco Dental AG have formed a strategic partnership to enhance digital dentistry through the introduction of CROWNTEC™ material in the U.S. This new composite resin is 30% stronger than previous crown & bridge materials and enables the production of biocompatible crowns and restorations using 3D Systems' NextDent® 5100 digital dentistry solution. CROWNTEC is CE-marked and has received 510(k) clearance, available in various shades to ensure natural aesthetics. This collaboration aims to improve efficiency and patient outcomes in dental labs and clinics.
3D Systems (NYSE:DDD) will release its financial results for Q4 and full year 2021 on February 28, 2022, after U.S. markets close. A conference call and webcast will take place the same day at 4:30 p.m. Eastern Time to discuss these results. The company will also file its Form 10-K on March 1, 2022. 3D Systems is a leader in Additive Manufacturing with over 30 years of innovation, offering a range of solutions for sectors like healthcare, aerospace, and automotive.
3D Systems (NYSE:DDD) will present virtually at the 24th Annual Needham Virtual Growth Conference on January 12, 2022, at 10:45 a.m. ET. Investors can access the live webcast in the 'Events and Presentations' section of the company’s website, where it will also be available for replay for at least 30 days post-event. The press release includes forward-looking statements with associated risks and uncertainties that may impact future performance. 3D Systems continues to be a leader in additive manufacturing, offering innovative solutions across healthcare and industrial markets.
3D Systems announced the immediate appointment of Claudia Napal Drayton to its Board of Directors. Drayton, who is currently the CFO of Quantum-Si, brings extensive experience in finance and the healthcare sector, notably from her prior role at Medtronic. The board's chairman, Chip McClure, highlighted her expertise as invaluable for future growth in medical devices and regenerative medicine. Drayton expressed enthusiasm for the company's innovative potential in healthcare applications, emphasizing opportunities for growth and value creation.
3D Systems has successfully completed an upsized offering of $460 million in 0% convertible senior notes due 2026. The offering includes $60 million from the initial purchasers' option. The notes do not accrue interest and will mature on November 15, 2026. They have an initial conversion rate of 27.8364 shares per $1,000 principal amount, representing a 42.5% premium over the recent stock price. Net proceeds of approximately $446 million will be used for general corporate purposes, including potential acquisitions. The offering was made to qualified institutional buyers under Rule 144A.
3D Systems (NYSE: DDD) has unveiled several innovations aimed at advancing additive manufacturing across healthcare and industrial sectors. Key highlights include the launch of the SLS 380 for enhanced part production, the DMP Flex 350 Dual and DMP Factory 350 Dual which reduce build times significantly, and the DMP Flex 200 optimized for dental applications. Additional advancements include the 3DXpert® 17 software for improved design workflows and the Figure 4® Rigid 140C Black material for automotive applications, showcasing the company's commitment to delivering innovative solutions in 3D printing.
3D Systems has priced its offering of $400 million in 0% convertible senior notes due 2026, raising the initial offering from $350 million. The sale is expected to close on November 16, 2021. The notes, with a conversion rate of 27.8364 shares per $1,000 principal, represent a 42.5% premium over the recent stock price. Estimated net proceeds are around $388 million, intended for general corporate purposes, including potential acquisitions. The offering is made under Rule 144A and involves risks that could affect the company's future performance.
3D Systems announced a proposed offering of $350 million of convertible senior notes due 2026. An additional $52.5 million may be purchased by initial investors within 13 days of issuance. The notes will be unsecured and interest will be paid semiannually. They can be converted under certain conditions until 2026, upon which 3D Systems may pay cash, stock, or a combination upon conversion. The net proceeds will support general corporate purposes, including potential acquisitions. This offering is private and subject to market conditions.
3D Systems Corporation (NYSE:DDD) reported Q3 2021 revenue of $156.1 million, reflecting a 14.6% increase year-over-year. Adjusted for divestitures, revenue grew 35.9% compared to 2020. The company achieved a 10.5% adjusted EBITDA margin and generated $20.7 million in positive cash flow, marking four consecutive quarters of positive operations. Following divestitures, cash reserves stand at $502.8 million with no debt. 3D Systems announced acquisitions of Oqton and Volumetric Biotechnologies to drive future high-margin growth. Gross profit margin was 41.2%.
3D Systems announces an expansion of its collaboration with United Therapeutics to develop bioprinting technology for multiple human organs, beyond just lungs. This amendment will take effect once 3D Systems completes its acquisition of Volumetric Biotechnologies, Inc. The program aims to provide an unlimited supply of biocompatible human organs for transplantation, relying on a technology platform established since 2017. The initiative is projected to continue through 2025, reflecting the companies' commitment to addressing urgent medical needs for organ transplants.